My most serious pharmacy mistakeOver the course of a career, errors are inevitable. For pharmacists, who never forget that lives are at stake, the prospect is chilling. Yet close calls still happen. This was one. New website streamlines REMS dataFDA's revamped REMS website enables users to find what they need and download it more easily. FDA meetings in July to address naloxone use, reformulated OxyContinAt the first meeting, stakeholders will explore ways to make naloxone more widely available. At the joint meeting, participants will evaluate post-marketing data for reformulated OxyContin. Retail pharmacy: Know the marketplace to grow the customer baseExpert tips on attracting and keeping retail pharmacy customers Pharmacists of America: Which side are you on?To relieve intractable working conditions, pharmacists will have to join together. It's time to unionize. FDA advisors favor new cholesterol-lowering drugs that target PCSK9FDA advisory committee okays two monoclonal antibody formulations in two days for treatment of hypercholesterolemia. Helping smokers kick the habit: 7 tips for pharmacists June 10, 2015By Randy DotingaEach option has drawbacks. Bottom line: The ideal choice is the one the patient will actually use. Rivaroxaban for inherited thrombophilia: A case studyIs rivaroxaban the best therapeutic option for this patient? Drug Topics Voices 06-10-2015
June 10, 2015Letters, e-mails, posts, and comments from Drug Topics readers
Washington insurers to recognize provider statusA groundbreaking bill passes in Washington state, CVS Health to buy Omnivore, FIP in Dusseldorf, and more.